Global Biopharmaceuticals Market Size & Trends Report Segmented by Product (mAbs, Recombinant Proteins, Vaccines, Gene & Cell Therapies), Type (Innovative, Biosimilars), Therapy Area (Oncology, Autoimmune Diseases, Infectious Diseases, Rare Diseases) Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Biopharmaceuticals Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • Mic population
  • Expansion of biosimilars
  • Rising R&D investments
  • Restraints
    • High development and manufacturing costs
    • Complex regulatory processes
    • Patent cliffs and market competition
    • High production costs
    • Challenges in drug stability and storage
  • Opportunities
    • Expansion in emerging markets
    • Innovations in drug delivery systems
    • Personalized medicine
    • Expanding applications in rare diseases
  • Key Market Trends
    • Emergence of gene and cell therapies
    • Advancements in mRNA technology
    • Emphasis on bioprocessing innovations
    • Combination therapies
  • Unmet Market Needs
  • Industry Speaks
  • Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Product, USD Million
    • Introducbs)
    • Recombinant Proteins
    • Vaccines
    • Gene Therapies and Cell Therapies
    • Others
  • Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Type, USD Million
    • Introduction
    • Innovative
    • Biosimilars
  • Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Therapy Area, USD Million
    • Introduction
    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Neurological Disorders
    • Rare/Orphan Diseases
    • Others
  • Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
    • Introduction
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Region, USD Million
      • Introduction
      • North America Biopharmaceuticals Market Size & Forecast (2023-2030), By Country, USD Million
        • US
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Type (USD Million)
          • Market Size & Forecast, By Therapy Area (USD Million)
          • Market Size & Forecast, By Distribution Channel (USD Million)
        • Canada
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Type (USD Million)
          • Market Size & Forecast, By Therapy Area (USD Million)
          • Market Size & Forecast, By Distribution Channel (USD Million)
      • Europe Biopharmaceuticals Market Size & Forecast (2023-2030), By Country,
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • Germany
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • France
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • Italy
      • Market Size & Forecast, By Product (USD Million)
      • Market Siarket Size & Forecast, By Distribution Channel (USD Million)
    • Spain
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • Rest of Europe
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
  • Asia Pacific (APAC) Biopharmaceuticals Market Size & Forecast (2023-2030), By Country, USD Million
    • China
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Fket Size & Forecast, By Distribution Channel (USD Million)
    • Japan
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • India
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Market Size & Forecast, By Distribution Channel (USD Million)
    • Rest of Asia Pacific
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Therapy Area (USD Million)
      • Markopharmaceuticals Market Size & Forecast (2023-2030), USD Million
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Therapy Area (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Middle East & Africa (MEA) Biopharmaceuticals Market Size & Forecast (2023-2030), USD Million
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Therapy Area (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2023-2025)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  • Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
      • AbbVie Inc.
      • Amgen Inc.
      • AstraZeneca
      • Eli Lilly and Co.
      • Johnson & Johnson
      • Merck & Co.
      • Novartis
      • Novo Nordisk
      • Pfizer Inc.
      • Roche Holding AG
      • Other Prominent Players

    Note *Indicative list

    **For liste